Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.
Journal of Cellular Physiology|June 17, 2011
Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancerUzma Shamim, Sarmad Hanif, Abdulmajeed Albanyan, et al.
International Journal of Molecular Sciences|October 2, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric CancerRachel Sexton, Zaid Mahdi, Rahman Chaudhury, et al.
International Journal of Molecular Sciences|January 8, 2020
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy ResistanceHusain Yar Khan, James Ge, Misako Nagasaka, et al.
Scientific Reports|November 6, 2015
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S Azmi, Irfana Muqbil, Jack Wu, et al.
Cancers|January 11, 2022
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell LymphomaHusain Yar Khan, Md Hafiz Uddin, Suresh Kumar Balasubramanian, et al.
Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.
Advances in Radiation Oncology|December 8, 2022
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan, Mandana Kamgar, Amro Aboukameel, et al.
Pageof 19